Antiviral resistance in influenza viruses - Implications for management and pandemic response

被引：145

作者：

Hayden, FG ^{[1
]}

机构：

[1] Univ Virginia, Sch Med, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 08期

关键词：

D O I：

10.1056/NEJMp068030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：785 / 788

页数：4

共 5 条

[1] Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern [J].

Bright, RA ;

Medina, MJ ;

Xu, XY ;

Perez-Oronoz, G ;

Wallis, TR ;

Davis, XHM ;

Povinelli, L ;

Cox, NJ ;

Klimov, AI .

LANCET, 2005, 366 (9492) :1175-1181

[2]

BRIGHT RA, IN PRESS JAMA

[3] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].

de Jong, MD ;

Thanh, TT ;

Khanh, TH ;

Hien, VM ;

Smith, GJD ;

Chau, NV ;

Cam, BV ;

Qui, PT ;

Ha, DQ ;

Guan, Y ;

Peiris, JSM ;

Hien, TT ;

Farrar, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672

[4]

Hayden F, 2005, ANTIVIR THER, V10, P873

[5] Low incidence of rimantadine resistance in field isolates of influenza A viruses [J].

Ziegler, T ;

Hemphill, ML ;

Ziegler, ML ;

Perez-Oronoz, G ;

Klimov, AI ;

Hampson, A ;

Regnery, HL ;

Cox, NJ .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :935-939

← 1 →